Precigen (PGEN) Other Accumulated Expenses (2012 - 2026)
Precigen (PGEN) reported Other Accumulated Expenses of $12.5 million for Q1 2026, up 90.03% year-over-year from $6.6 million in Q1 2025, and up 13.54% quarter-over-quarter from $11.0 million in Q4 2025.
Precigen (PGEN) Other Accumulated Expenses (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Other Accumulated Expenses data on file, last reported at $12.5 million in Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $12.5 million, up 90.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.5 million (up 90.03% YoY), and the FY2025 annual result was $11.0 million, up 128.45% from the prior year.
- Other Accumulated Expenses advanced to $12.5 million in Q1 2026 per PGEN's latest filing, from $11.0 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $22.9 million in Q1 2023 and troughed at $3.3 million in Q2 2023.
- A 5-year average of $8.7 million and a median of $7.3 million in 2024 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses sank 68.12% in 2024, then surged 128.45% in 2025.
- A 5-year view of Other Accumulated Expenses shows it stood at $5.0 million in 2022, then increased by 24.53% to $6.2 million in 2023, then retreated by 22.67% to $4.8 million in 2024, then surged by 128.45% to $11.0 million in 2025, then grew by 13.54% to $12.5 million in 2026.
- Business Quant data shows PGEN's Other Accumulated Expenses at $12.5 million in Q1 2026, $11.0 million in Q4 2025, and $10.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Precigen | 1.32 Bn | 1.32 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.48 Mn |
| Dec 31, 2025 | 10.99 Mn |
| Sep 30, 2025 | 10.82 Mn |
| Jun 30, 2025 | 9.51 Mn |
| Mar 31, 2025 | 6.57 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Sep 30, 2024 | 5.68 Mn |
| Jun 30, 2024 | 6.64 Mn |
| Mar 31, 2024 | 7.30 Mn |
| Dec 31, 2023 | 6.22 Mn |
| Sep 30, 2023 | 4.12 Mn |
| Jun 30, 2023 | 3.26 Mn |
| Mar 31, 2023 | 22.89 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 11.69 Mn |
| Jun 30, 2022 | 9.67 Mn |
| Mar 31, 2022 | 10.49 Mn |
| Dec 31, 2021 | 7.82 Mn |
| Sep 30, 2021 | 11.26 Mn |
| Jun 30, 2021 | 10.47 Mn |